Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis-Reference-Cited by-同舟云学术

Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis

Published:2021-10-29 Issue:6 Volume:11 Page:2147-2157
ISSN:2193-8210
Container-title:Dermatology and Therapy
language:en
Short-container-title:Dermatol Ther (Heidelb)

Author:

Yosipovitch Gil^ORCID,de Bruin-Weller Marjolein^ORCID,Armstrong April^ORCID,Wu Jashin J.^ORCID,Herranz Pedro^ORCID,Thaçi Diamant^ORCID,Delevry Dimittri^ORCID,Bagousse Gaëlle Bégo-Le,Zhang Raymond^ORCID,Shumel Brad^ORCID,Rossi Ana B.^ORCID,Chao Jingdong

Funder

Sanofi

Regeneron Pharmaceuticals

Publisher

Springer Science and Business Media LLC

Subject

Dermatology

Link

https://link.springer.com/content/pdf/10.1007/s13555-021-00630-9.pdf

Reference20 articles.

1. Haeck IM, ten Berge O, van Velsen SG, de Bruin-Weller MS, Bruijnzeel-Koomen CA, Knol MJ. Moderate correlation between quality of life and disease activity in adult patients with atopic dermatitis. J Eur Acad Dermatol Venereol. 2012;26(2):236–41.

2. Kim DH, Li K, Seo SJ, et al. Quality of life and disease severity are correlated in patients with atopic dermatitis. J Korean Med Sci. 2012;27(11):1327–32.

3. Weidinger S, Beck LA, Bieber T, Kabashima K, Irvine AD. Atopic dermatitis. Nat Rev Dis Primers. 2018;4(1):1.

4. European Medicines Agency. DUPIXENT® (dupilumab). Summary of product characteristics. https://www.ema.europa.eu/en/documents/product-information/dupixent-epar-product-information_en.pdf. Accessed June 2021.

5. US Food and Drug Administration. DUPIXENT® (dupilumab). Highlights of prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761055s020lbl.pdf. Accessed June 2021.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improved sleep parallels improvements in atopic dermatitis signs, symptoms, and quality of life in adult patients treated with dupilumab: 24-week results from the DUPISTAD study;Journal of the American Academy of Dermatology;2024-07

2. Exploring the interplay of atopic dermatitis severity with sleep and mental health: a case-control study in adult patients;Postgraduate Medicine;2024-06-12

3. Interventions for anxiety and depression in patients with atopic dermatitis: a systematic review and meta-analysis;Scientific Reports;2024-04-17

4. Neuroimmune interplay during type 2 inflammation: Symptoms, mechanisms, and therapeutic targets in atopic diseases;Journal of Allergy and Clinical Immunology;2023-08